Table 1.
Characteristics of studies comparing patients with post-ACLR septic arthritis and those without it
| No. | Study [year] | Study design Country |
LOE | Study characteristics | No. of patients | Age (years), mean ± SD | Male, n (%) | Primary ACLR, n (%) | Graft type, n (%) | Prior knee procedure, n (%) | Concomitant surgery, n (%) | Follow-up period (months), mean ± SD (range) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BPTB | Hamstring | Allograft | ||||||||||||
| 1 | Abdel-Aziz [17] |
Prospective Egypt |
II | Patients with ACLR with hamstring autograft; 2004–2011; CU |
S: 24 N: 24 |
S: 26 ± 5 N: 27 ± 4 |
S: 24 (100) N: 24 (100) |
NR |
S: 0 (0) N: 0 (0) |
S: 24 (100) N: 24 (100) |
S: 0 (0) N: 0 (0) |
S: 4 (17) N: NR |
NR |
S: 59 ± 21 (18–96) N: 55 ± 22 (18–96) |
| 2 | Bohu [18] |
Prospective France |
III | Patients with ACLR; 2012–2016; CdS |
S: 7 N: 1802 |
S: 36.4 ± 13.7 N: 29.1 ± 9.7 |
S: 6 (86) N: 1626 (90) |
S: 5 (71) N: 1627 (90) |
S: 2 (29) N: 172 (0.1) |
S: 5 (71) N: 1520 (84) |
S: 0 (0) N: 0 (0) |
S: 4 (57) N: 210 (12) |
694 (38)b 61 (3)c 376 (21)d 355 (20)e |
33.6 ± 14.4 (18.0–57.6) |
| 3 | Boström Windhamre [19] |
Retrospective Sweden |
III | Patients with primary ACLR; 2001–2009; CAC with complete rehabilitation |
S: 27 N: 27 |
S: 27 (16–43)* N: 28 (14–43)* |
S: 13 (48) N: 13 (48) |
S: 27 (100) N: 27 (100) |
S: 0 (0) N: 0 (0) |
S: 27 (100) N: 27 (100) |
S: 0 (0) N: 0 (0) |
S: 11 (41) N: 12 (44) |
S: 10 (37)f N: 9 (33)f |
S: 60 (13–108)* N: 66 (16–114)* |
| 4 | Brophy [20] |
Prospective United States |
IV | Patients with ACLR; 2002–2008; MOON |
S: 21 N: 3189 |
S: 25.8 ± 11.3 N: 26.6 ± 11.0 |
S: 12 (57) N: 1778 (56) |
S: 18 (86) N: 2982 (94) |
S: 4 (19) N: 1401 (44) |
S: 12 (57) N: 1093 (34) |
S: 5 (24) N: 695 (22) |
NR | NR |
S: 78 ± 3.6 N: 78 ± 4.8 |
| 5 | Calvo [21] |
Retrospective Chile |
IV | Patients with primary ACLR with hamstring autograft; 2000–2011; CA |
S: 7 N: 1557 |
S: 27.8 (14–51)* N: 28.3 (14–55)* |
S: 7 (100) N: 1281 (82) |
S: 7 (100) N: 1557 (100) |
S: 0 (0) N: 0 (0) |
S: 7 (100) N: 1557 (100) |
S: 0 (0) N: 0 (0) |
S: 0 (0) N: 20 (1) |
S: 3 (42)f N: 745 (48)a,f,g |
18–108† |
| 6 | Meglic [22] |
Prospective Slovenia |
II | Patients with primary ACLR; 2004–2014; UMCL with complete rehabilitation |
S: 18 N: 20 |
S: 31 ± 7 N: 33 ± 6 |
S: 11 (61) N: 12 (60) |
S: 18 (100) N: 20 (100) |
S: 11 (61) N: 12 (60) |
S: 7 (39) N: 8 (40) |
S: 0 (0) N: 0 (0) |
NR |
S: 2 (11)a N: 2 (10)a |
S: 48 ± 4 (42–56) N: 48 ± 4 (42–56) |
| 7 | Schollin-Borg [7] | Retrospective, Sweden | III | Patients with ACLR; 1996–1999; UUH |
S: 10 N: 10 |
S: 28.3 ± 5.5 N: 29.1 ± 5.7 |
S: 8 (80) N: 8 (80) |
NR |
S: 6 (60) N: 6 (60) |
S: 4 (40) N: 3 (30) |
S: 0 (0) N: 0 (0) |
S: 5 (50) N: 7 (70) |
S: 4 (40)f,g N: 2 (20)f |
36** |
| 8 | Torres-Claramunt [23] |
Retrospective, Spain |
IV | Patients with ACLR; 2006–2009; PdSM and ICATME with rehabilitation |
S: 15 N: 15 |
S: 33.5 ± 7.6 N: 34.7 ± 7.6 |
S: 12 (76) N: 10 (67) |
NR |
S: 4 (27) N: 5 (33) |
S: 11 (73) N: 10 (67) |
S: 0 (0) N: 0 (0) |
NR |
S: 3 (20)f N: NR |
S: 39.3 ± 13 N: 42.6 ± 7.5 |
*Mean (range), †Range, and **Mean
aMeniscal repair
bExtra-articular tenodesis (tensor fasciae latae)
cChondroplasty
dPartial medial meniscectomy and suturing
ePartial lateral meniscectomy and suturing
fMeniscectomy
gMeniscus microfracture
ACLR anterior cruciate ligament reconstruction, BPTB bone–patellar tendon–bone graft, CA Clinica Alemana, CAC Capio Artro Clinic, CdS Clinique du Sport, CU Cairo University, ICATME ICATME-Institut Universitari Dexeus, LOE level of evidence, MOON Multicenter Orthopaedic Outcomes Network knee group, N patients without post-ACLR septic arthritis, NR not reported, PdSM Parc de Salut Mar, S patients with septic arthritis, SD standard deviation, UMCL University Medical Centre Ljublijana, UUH Uppsala University Hospital